Compass Diversified heads into its Q1 results — reported after the close on May 6 — carrying one of the stranger setups of the week: a CFO who bought the stock at $8.50 in early April and is sitting on a 37% gain, a completed $292.5 million asset sale, and a short base that has quietly been retreating for the past month.
The insider angle is the sharpest entry point into this story. CFO Stephen Keller bought 30,000 shares in two tranches on April 6, paying $8.50 and $8.66 respectively, for a combined outlay of roughly $258,000. That was a low point; the stock closed Tuesday at $11.63. The purchases followed a prolonged sell-off that had taken CODI well below the levels where Keller had bought in prior years — he also added shares in September 2024 around $21 and in March 2025 at $22 — suggesting the April buy was a deliberate show of conviction at a price the CFO clearly judged to be an overshoot. Net insider purchases over the trailing 90 days total 30,000 shares at a net cost of $258,000 — modest in absolute dollar terms, but the signal is unambiguous when the buyer is the CFO and the stock had just cut in half.
The positioning data backs a market that is incrementally less pessimistic. Short interest came in at roughly 7.8% of free float as of May 5, down about 2.5% over the past month and edging lower through the week. That is a meaningful short base, but the direction of travel matters: bears have been trimming rather than adding. The borrow market is essentially wide open — availability runs at nearly 1,200% of short interest, meaning there is no shortage of shares for would-be shorts and zero squeeze pressure in the lending pool. Cost to borrow has also eased, dropping 15% week-over-week to 0.44%, its lowest reading in roughly six weeks. The ORTEX short score of 47.7 sits in the lower-middle of the range, consistent with a stock where shorts exist but are not pressing hard. Options positioning is similarly relaxed: the put/call ratio of 0.018 is near its 52-week low, below the 20-day average, suggesting minimal demand for downside protection heading into the print.
The Q1 results themselves give bulls and bears something to argue about. EPS of -$0.62 beat the -$0.64 consensus estimate, a small but clean beat. Revenue of $426.9 million missed the $437.7 million estimate by about 2.5%, with 5.11 and PrimaLoft showing declines while the BOA active lifestyle segment paced growth. The company also issued 2026 subsidiary adjusted EBITDA guidance of $320 million to $365 million. The $292.5 million sale of Sterno's food service business to Archer Foodservice Partners, completed May 4, provides a balance-sheet catalyst; how management deploys that capital is now the central question for the next several months. A follow-on earnings event is already scheduled for May 21.
The analyst picture is thin. B. Riley Securities is the only firm with a clearly current action on record. They raised their target to $10.50 from $8.00 on April 7 while maintaining a Neutral rating — a move that followed two earlier target cuts in January and March that had compressed their view from $18.00 down to $8.00. The mean analyst price target from the most recent available data is $12.75. At $11.63 that implies modest upside, but with only B. Riley generating recent activity and the broader analyst history largely pre-dating 2025's sell-off, the Street's current read on CODI is difficult to triangulate with confidence. Earlier targets from TD Cowen ($34) and B of A Securities ($30) are too stale to be useful.
ADW Capital Management is worth watching on the institutional side. The firm reported a fresh 3.75 million share position as of April 2, representing roughly 5% of shares outstanding — a position that went from zero in the prior filing. That is the kind of concentrated, newly-initiated stake from an active manager that often signals a thesis in motion. American Century and Allspring both added modestly in Q1, while core holders Compass Group Investments and Mangrove Partners held flat.
The setup into the May 21 follow-on event is therefore less about whether CODI can grow and more about whether the Sterno proceeds signal a genuine portfolio reorientation — or simply a cleanup of a non-core asset before conditions deteriorate further.
See the live data behind this article on ORTEX.
Open CODI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
